META vs. GILD

Last updated Jun 6, 2026

META (Meta Platforms, Inc.) and GILD (Gilead Sciences, Inc.) are both stocks. META operates in Internet Content & Information (Communication Services), while GILD operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, META returned 17.64%/yr vs 7.71%/yr for GILD. At a 0.22 correlation, their price movements are largely independent.

Performance

META vs. GILD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Meta Platforms, Inc. (META) and Gilead Sciences, Inc. (GILD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, META achieves a -10.09% return, which is significantly lower than GILD's 5.83% return. Over the past 10 years, META has outperformed GILD with an annualized return of 17.64%, while GILD has yielded a comparatively lower 7.71% annualized return.

META

• 1D: -5.51%
• 1M: -3.24%
• YTD: -10.09%
• 6M: -11.79%
• 1Y: -13.11%
• 3Y*: 30.15%
• 5Y*: 12.59%
• 10Y*: 17.64%

GILD

• 1D: -0.02%
• 1M: -5.24%
• YTD: 5.83%
• 6M: 7.86%
• 1Y: 20.04%
• 3Y*: 23.34%
• 5Y*: 18.21%
• 10Y*: 7.71%

*Multi-year figures are annualized to reflect compound growth (CAGR)

META vs. GILD - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
META Meta Platforms, Inc.	-10.09%	13.09%	66.05%	194.13%	-64.22%	23.13%	33.09%	56.57%	-25.71%	53.38%
GILD Gilead Sciences, Inc.	5.83%	36.59%	18.68%	-1.99%	23.63%	29.95%	-6.70%	7.88%	-9.92%	2.96%

Correlation

The correlation between META and GILD is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.01
Correlation (3Y) Calculated over the trailing 3-year period	0.01
Correlation (5Y) Calculated over the trailing 5-year period	0.11
Correlation (10Y) Calculated over the trailing 10-year period	0.18
Correlation (All Time) Calculated using the full available price history since May 21, 2012	0.22

Over the past year, the correlation between META and GILD has dropped to 0.01 - well below their long-term average of 0.22, suggesting their price drivers have been diverging.

Fundamentals

Market Cap META : $1.52T GILD : $161.97B
EPS META : $27.47 GILD : $7.35
PE Ratio META : 21.59 GILD : 17.57
PEG Ratio META : 0.89 GILD : 0.04
PS Ratio META : 7.09 GILD : 5.45
PB Ratio META : 6.24 GILD : 6.89
Total Revenue (TTM) META : $214.96B GILD : $29.74B
Gross Profit (TTM) META : $176.14B GILD : $18.74B
EBITDA (TTM) META : $106.31B GILD : $12.88B

Return for Risk

META vs. GILD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

META

META Risk / Return Rank: 25
META Sharpe Ratio Rank: 25
META Sortino Ratio Rank: 24
META Omega Ratio Rank: 24
META Calmar Ratio Rank: 28
META Martin Ratio Rank: 25

GILD

GILD Risk / Return Rank: 63
GILD Sharpe Ratio Rank: 66
GILD Sortino Ratio Rank: 61
GILD Omega Ratio Rank: 57
GILD Calmar Ratio Rank: 64
GILD Martin Ratio Rank: 65

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

META vs. GILD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Meta Platforms, Inc. (META) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	META	GILD	Difference
Sharpe ratio: Return per unit of total volatility	-0.37	0.77	-1.14
Sortino ratio: Return per unit of downside risk	-0.31	1.30	-1.61
Omega ratio: Gain probability vs. loss probability	0.96	1.15	-0.19
Calmar ratio: Return relative to maximum drawdown	-0.40	1.14	-1.54
Martin ratio: Return relative to average drawdown	-0.84	2.82	-3.66
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

META vs. GILD - Sharpe Ratio Comparison

The current META Sharpe Ratio is -0.37, which is lower than the GILD Sharpe Ratio of 0.77. The chart below compares the historical Sharpe Ratios of META and GILD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	META	GILD	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.37	0.77	-1.14
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.29	0.76	-0.47
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.46	0.30	+0.15
Sharpe Ratio (All Time) Calculated using the full available price history	0.55	0.39	+0.16

Drawdowns

META vs. GILD - Drawdown Comparison

The maximum META drawdown since its inception was -76.74%, which is greater than GILD's maximum drawdown of -70.83%. Use the drawdown chart below to compare losses from any high point for META and GILD.

Drawdown Indicators

	META	GILD	Difference
Max Drawdown Largest peak-to-trough decline	-76.74%	-70.83%	-5.91%
Max Drawdown (1Y) Largest decline over 1 year	-33.30%	-17.65%	-15.65%
Max Drawdown (3Y) Largest decline over 3 years	-34.15%	-26.59%	-7.56%
Max Drawdown (5Y) Largest decline over 5 years	-76.74%	-26.59%	-50.15%
Max Drawdown (10Y) Largest decline over 10 years	-76.74%	-30.47%	-46.27%
Current Drawdown Current decline from peak	-24.76%	-16.63%	-8.13%
Average Drawdown Average peak-to-trough decline	-15.26%	-22.16%	+6.90%
Ulcer Index Depth and duration of drawdowns from previous peaks	15.60%	7.13%	+8.47%

Volatility

META vs. GILD - Volatility Comparison

Meta Platforms, Inc. (META) has a higher volatility of 10.46% compared to Gilead Sciences, Inc. (GILD) at 6.88%. This indicates that META's price experiences larger fluctuations and is considered to be riskier than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	META	GILD	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.46%	6.88%	+3.58%
Volatility (6M) Calculated over the trailing 6-month period	27.14%	18.53%	+8.61%
Volatility (1Y) Calculated over the trailing 1-year period	35.52%	26.31%	+9.21%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	44.04%	24.02%	+20.02%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	38.68%	25.48%	+13.20%

Dividends

META vs. GILD - Dividend Comparison

META's dividend yield for the trailing twelve months is around 0.35%, less than GILD's 2.47% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
GILD Gilead Sciences, Inc.	2.47%	2.57%	3.33%	3.70%	3.40%	3.91%	4.67%	3.88%	3.65%	2.90%	2.57%	1.27%
META Meta Platforms, Inc.	0.35%	0.32%	0.34%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

META vs. GILD - Profitability Comparison

The chart below illustrates the profitability comparison between Meta Platforms, Inc. and Gilead Sciences, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

META - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported a gross profit of 46.09B and revenue of 56.31B. Therefore, the gross margin over that period was 81.9%.

GILD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Gilead Sciences, Inc. reported a gross profit of 79.20M and revenue of 6.96B. Therefore, the gross margin over that period was 1.1%.

META - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported an operating income of 22.87B and revenue of 56.31B, resulting in an operating margin of 40.6%.

GILD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Gilead Sciences, Inc. reported an operating income of 2.59B and revenue of 6.96B, resulting in an operating margin of 37.2%.

META - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported a net income of 26.77B and revenue of 56.31B, resulting in a net margin of 47.5%.

GILD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Gilead Sciences, Inc. reported a net income of 2.02B and revenue of 6.96B, resulting in a net margin of 29.0%.

Frequently Asked Questions

Can I hold both META and GILD in my portfolio?

META and GILD have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, META or GILD?

META has higher volatility (10.46%) compared to GILD (6.88%). In terms of maximum drawdown, META dropped -76.74% vs GILD's -70.83%.

Which has better risk-adjusted returns?

GILD currently has the higher Sharpe Ratio (0.77 vs -0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.